Pharmaceutical Executive
April 23, 2020
Features
40
4
For Sandra Horning, this year's Healthcare Businesswomen’s Association Woman of the Year, harnessing the patient experience has been the driving force in a career-spanning-and service-focused-mission to fight disease and accelerate the delivery of new medicines.
April 22, 2020
Features
40
4
Recognizing that diversity and inclusion is no longer simply a “nice to have,” pharma has boosted efforts in this areas. But just how far are new industry initiatives moving the needle on D&I?
April 10, 2020
From the Editor
40
4
Speculating the downstream impact on industry practices is just that right now-speculation. What is sure is some things will never be the same, and some things could even get better.
April 09, 2020
Columns
40
4
The key to success in a hypercompetitive marketplace is to create targeting plans that get ahead of tomorrow’s prescriptions.
April 08, 2020
Columns
40
4
With coronavirus a stark backdrop, European initiative pushes for “fair” drug prices to spur investment in pharma innovation.
April 08, 2020
Features
40
4
A follow-up survey of clinical and financial health plan leaders uncovers evolving approaches and views on the management of high-cost, curative-intended treatments with one-time administration.
April 01, 2020
Columns
40
4
Emergency funds for research, public health, and economic disaster raise access issues.
April 01, 2020
Columns
40
4
Strategies for those chief information officers taking the digital reins at their organizations.
April 01, 2020
Issue PDF
40
4
Click the title above to open the Pharmaceutical Executive April 2020 issue in an interactive PDF format.
April 01, 2020
Special Sponsored Section
40
4
Although still tightly regulated, healthcare industry stakeholders-buoyed by regulatory reforms aimed at increasing patient access to innovative new therapies-are cautiously optimistic that the Czech Republic will further close the gap with Western Europe.